TY - JOUR T1 - Report: Evaluating the ability of the TMA Clinical Decision Support platform to identify interventions in a clinical setting JF - medRxiv DO - 10.1101/2021.05.24.21257617 SP - 2021.05.24.21257617 AU - Joshua Resnikoff AU - Yessica Giraldo AU - Lina Williamson Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257617.abstract N2 - The TMA Precision Health Clinical Decision Support system is a commercially available software platform focused on the confirmation of a precision diagnosis and generation of a personalized care plan to rapidly deliver therapeutic optionality and improve quality of life for rare and complex disease patients. For this study, we worked with our partners in Medellin, Colombia to evaluate the efficacy of the platform in identifying previously unexplored modes of care within a small sample population of adult patients suffering from a diverse set of rare diseases. Although challenges were encountered during the curation of data from multiple sources, personalized care plans and medication options were identified successfully for 94% of cases, suggesting a high level of impact for deployment at scale.Competing Interest StatementTMA Precision Health is a partner of ION Health and helped underwrite this study.Funding StatementThe author(s) received no financial support for the research, authorship, and/or publication of this article.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was received by an independent IRB Review Board at the Universidad CES in Medellin, Antioquia, Colombia.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article. ER -